Showing results (171-180 of 544) with videos related to
Sort By:
Pageof 55
Vaccine: X|December 28, 2021
Reduced COVID-19 hospitalizations among New York City residents following age-based SARS-CoV-2 vaccine eligibility: Evidence from a regression discontinuity designSharon K Greene, Alison Levin-Rector, Emily McGibbon, et al.Vaccine: X|November 15, 2023
Importance of adjuvant selection in tuberculosis vaccine development: Exploring basic mechanisms and clinical implicationsHan Gyu Choi, Kee Woong Kwon, Sung Jae ShinVaccine: X|January 1, 2024
Unraveling the association between vaccine attitude, vaccine conspiracies and self-reported side effects following COVID-19 vaccination among nurses and physicians in JordanMalik Sallam, Hiba Abbasi, Rawan J Obeidat, et al.Vaccine: X|January 1, 2024
Antibody responses after BNT162b2 vaccination in Japanese geriatric intermediate care facilitiesAsae Suita, Satoko Ohfuji, Ayane Kasamatsu, et al.Vaccine: X|January 1, 2024
Association of COVID-19 information media, providers, and content with vaccine uptake among Tokyo residentsNoriko Noguchi, Ryosuke Yokoi, Taichi Masu, et al.Vaccine: X|December 22, 2023
Nationwide safety surveillance of COVID-19 mRNA vaccines following primary series and first booster vaccination in SingaporeSreemanee Raaj Dorajoo, Hui Xing Tan, Chun Hwee Desmond Teo, et al.Vaccine: X|December 13, 2023
Hybrid immunity from SARS-CoV-2 infection and mRNA BNT162b2 vaccine among Thai school-aged childrenKanchanok Saraban, Piyarat Suntarattiwong, Napaporn Chantasrisawad, et al.Vaccine: X|February 29, 2024
The cost of human papillomavirus vaccination delivery at the administrative and health facility levels in the PhilippinesJosephine G Aldaba, Cecilia L Llave, Ma Esterlita V Uy, et al.Vaccine: X|March 4, 2024
Individual and community-level determinants of pentavalent vaccination dropouts among under-five children in the sub-Saharan African countries: A multilevel analysis of the recent demographic and health surveyAlebachew Ferede Zegeye, Chilot Kassa Mekonnen, Hailemichael Kindie, et al.Vaccine: X|July 23, 2024
Safety profile assessment of HPV4 and HPV9 vaccines through the passive surveillance system of the Veneto Region (Italy) between 2008 and 2022: A 15-year retrospective observational studyDiana Dalla Valle, Roberto Benoni, Nicola Soriolo, et al.Pageof 55